Limd1, a LIM domain-containing protein, has been extensively studied in various cancers, where it has shown negative effects on tumor growth (Foxler et al. 2018; Zhou et al. 2019a, b; Huggins et al. 2017; Huggins and Andrulis 2008; Sharp et al. 2008; Liu et al. 2021). Here, LIMD1 is linked to neoplasm.